Angelini Pharma News and Activities

Angelini Pharma has a direct presence in 2 countries.

Acquisition, funding and merger involving Angelini Pharma.

• Angelini Pharma has announced the acquisition of Catalyst Pharmaceuticals  (posted on May 4 2026).

View the org chart displaying its 41 main executives

Most searched biographies at Angelini Pharma

• Sergio Condojanni, Chief Executive Officer
• Jacopo Andreose, Director
• Rosita Calabrese, Executive Director, West Europe and Intercontine...

Popular executive movements at Angelini Pharma

• Carlo Iavarone, who was Global Finance, Accounting and Controlling Director, is promoted to Senior Director, Corporate Finance  (posted on May 11 2026).
• Jacopo Andreose who was Chief Executive Officer, becomes Director  (posted on January 22 2026).

Create your alert
to follow the executive moves at Angelini Pharma.

Angelini Pharma has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Richard Saynor - Chief Executive Officer at Sandoz
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott

Learn more about the Pharmaceuticals industry

Press releases by Angelini Pharma

• The European House – Ambrosetti and Angelini Pharma present Headway Epilepsy Report
• Angelini Pharma appoints Rafal Kaminski as new Chief Scientific Officer
• Women and children hit hardest by mental health disorders during the pandemic: Headway 2023 Mental Health Index
• Angelini Pharma and Lumira Ventures launch the Angelini Lumira Biosciences Fund
• ONTOZRY® (cenobamate) receives European Commission approval for the treatment of drug-resistant focal-onset seizures in adults
• Epilepsy: talking about it at work is still a taboo
• Press kit
• Epilepsy: the obstacles to be overcome at work, in the relationships and in healthcare, in order to get out of hiding
• Angelini Pharma finalized the acquisition agreement of Arvelle Therapeutics
• Press Kit - Sala stampa - Angelini
• View more press releases Close

Social media about Angelini Pharma

• Angelini Pharma on Wikipedia, Google News & Yahoo Finance
• Angelini Pharma on LinkedIn, X (Twitter) & YouTube